You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 3, 2026

Claims for Patent: 10,246,537

✉ Email this page to a colleague

Summary for Patent: 10,246,537

Title:	Resin composition containing ethylene-vinyl alcohol copolymer, molded product, and multilayer structure
Abstract:	A resin composition according to an aspect of the present invention comprises: an ethylene-vinyl alcohol copolymer (A); and a block copolymer (B) having a block (b1) that includes a vinyl aromatic monomer unit, and a block (b2) that includes an isobutylene unit, wherein the ethylene-vinyl alcohol copolymer (A) and the block copolymer (B) form a co-continuous phase structure; and a DSC curve obtained following heating the resin composition up to a melting point and cooling at a rate of 50° C./min in a differential scanning calorimetry analysis shows two peaks, with a higher peak top temperature falling within a range of 130° C. or greater and 170° C. or less, and a lower peak top temperature falling within a range of 100° C. or greater and less than 130° C. A resin composition may thus be obtained that is able to give a molded article that is superior in balance between gas barrier properties and flexibility.
Inventor(s):	Wataru Hirose, Takeyuki Igarashi
Assignee:	Kuraray Co Ltd
Application Number:	US15/506,862

Details for Patent 10,246,537

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Elusys Therapeutics, Inc.	ANTHIM	obiltoxaximab	Injection	125509	March 18, 2016	10,246,537	2035-08-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,246,537

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016031652	⤷ Get Started Free
United States of America	2018148528	⤷ Get Started Free
United States of America	2017275403	⤷ Get Started Free
Japan	WO2016031652	⤷ Get Started Free
Japan	5998309	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.